Voya Asia Pacific High Dividend Equity Income Fund T.IAE

Primary Symbol: IAE

Voya Asia Pacific High Dividend Equity Income Fund (the Fund) is a diversified, closed-end management investment company. The Fund’s investment objective is total return through a combination of current income, capital gains and capital appreciation. The Fund seeks to achieve its investment objective by investing primarily in a portfolio of dividend yielding equity securities of Asia Pacific companies. The Fund will seek to achieve its investment objective by investing at least 80% of its managed assets in dividend producing equity securities of, or derivatives having economic characteristics similar to the equity securities of Asia Pacific Companies that are listed and traded principally on Asia Pacific exchanges. The Fund will invest in approximately 60-120 equity securities and will select securities through a bottom-up process that is based upon quantitative screening and fundamental analysis. Voya Investments, LLC is an investment adviser of the Fund.

NYSE:IAE - Post by User

Voya Asia Pacific High Dividend Equity Income Fund > I'm believe Delek knows what their doing

<< Previous

Bullboard Posts

Next >>

Post by Naka2112on Nov 24, 2015 5:50pm

127 Views

Post# 24321711

I'm believe Delek knows what their doing

Delek invested about 100 million CAD into iae at $1.05, yet there are some armchair critics worth a few grand here who claim to know better. Seriously, do these people believe that Delek didn't do their due diligence? Craziness.

Iae has has amazing hedges that protect part of their production
They will be producing close to 30,000 boe/d by the summer. They just redetermined their loans and have lots of financing room.

keep in mind today's volume was low, which simply suggests those with the nervous nellies are selling. Then someone dumped a thousand shares right at the close so that it would close down. That's manipulation that anyone with an iq of 4 or more can see through.

Jmo

<< Previous

Bullboard Posts

Next >>

One of the best Venture pharma stocks has grown even stronger